Search Results - "Ruiz Ribó, M D"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry by NIETO, J. A., SOLANO, R., RUIZRIBÓ, M. D., RUIZ‐GIMENEZ, N., PRANDONI, P., KEARON, C., MONREAL, M.

    Published in Journal of thrombosis and haemostasis (01-06-2010)
    “…Background: Fatal bleeding is a serious consequence of anticoagulant therapy, but factors associated with fatal bleeding during the first 3 months of treatment…”
    Get full text
    Journal Article
  2. 2

    Treatment of Human Brucellosis with Netilmicin and Doxycycline by Solera, Javier, Espinosa, Alfredo, Geijo, Paloma, Martínez-Alfaro, Elisa, Sáez, Lourdes, Sepúlveda, María Antonia, Ruiz-Ribó, María Dolores

    Published in Clinical infectious diseases (01-03-1996)
    “…We conducted a prospective, noncomparative, multicenter study to assess the safety and efficacy of doxycycline and netilmicin in the treatment of human…”
    Get full text
    Journal Article
  3. 3

    Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis by SOLERA, J, RODRIGUEZ-ZAPATA, M, GEIJO, P, LARGO, J, PAULINO, J, SAEZ, L, MARTINEZ-ALFARO, E, SANCHEZ, L, SEPULVEDA, M.-A, RUIZ-RIBO, M.-D

    “…Brucellosis is a common zoonosis in many parts of the world; the best regimen for the treatment of brucellosis has not been clearly determined. We have carried…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    The risk-benefit of the treatment of tuberculosis with a high bacilloscopy sensitivity in a provincial hospital by Geijo Martínez, M P, Martínez Medina, C, Herranz, C, Ruiz Ribó, M D

    “…To know the incidence and type of hepatic toxicity (HTX) of the tuberculous chemotherapy and to value the risk-benefit of treatment in our elderly population…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Progressive multifocal leukoencephalopathy and AIDS. Response to cytarabine by Hervas Laguna, M J, Nieto Rodríguez, J A, Geijo Martínez, M P, Ruiz Ribo, M D, Borregón, S

    “…PML affects 4% of patients with AIDS and there is no effective treatment. Five cases of PML-AIDS have been described, showing clinical and radiological…”
    Get more information
    Journal Article